In the News

Learn what bladder cancer symptoms can mean in men and women.

Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This new drug combination also has fewer side effects than other immunotherapy treatments.

Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.

Memorial Sloan Kettering plastic and reconstructive surgeon Peter Cordeiro describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.

Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.

Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.

Learn about cryoablation for breast cancer at Memorial Sloan Kettering Cancer Center.

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.

Learn what blood in the urine may mean, and why you should never ignore it.